Shortcut Navigation:

Breast Cancer News

In this section, access cutting-edge breast cancer news on treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.

Perjeta Safe and Effective for Older Women With HER2-positive Metastatic Breast Cancer

Women 65 and older received the same treatment benefit from the combination of pertuzumab (Perjeta), trastuzumab (Herceptin) and docetaxel (Taxotere) as women 64 and younger, a sub-analysis of CLEOPATRA trial data reveals. 

News From the San Antonio Breast Cancer Symposium

Each December, medical experts and researchers from around the world meet at the 5-day San Antonio Breast Cancer Symposium to share the latest findings from breast cancer clinical trials. Read on for updates from the 2013 symposium, held December 10–14.

Women Report Positive Life Changes After Challenge of Breast Cancer

Despite anxiety that can arise from a breast cancer diagnosis, a recent study shows that in the year that follows women may experience post-traumatic growth, or positive changes to the way they view relationships, themselves or their lives. 

AbbVie Drug Shows Promise Against Difficult Type of Breast Cancer

(Reuters) - Women with an especially deadly type of breast cancer who received a treatment regimen containing an experimental AbbVie Inc drug prior to surgery are likely to have a significantly better response than those who get a standard chemotherapy regimen, according to data from a clinical trial.

Yoga Improves Sleep Quality After Cancer Treatment

People 2 to 24 months post-cancer treatment may find relief from lingering sleep issues that developed during or after treatment by practicing yoga twice a week, a study published in the Journal of Clinical Oncology shows. 

Shorter Radiation Schedule as Effective as Standard

An analysis of 10 years of data from the UK Standardization of Breast Radiotherapy (START) trials A and B shows women with early-stage breast cancer may be able to have radiation therapy for a shorter amount of time, yet get the same treatment benefit. 

Radiation Reduces Risk of DCIS Recurrence by Almost 50 Percent

An analysis of 15 years of data from the European Organization for Research and Treatment of Cancer study 10853 shows women with ductal carcinoma in situ (DCIS), the earliest stage of breast cancer, may reduce their risk of the cancer coming back by as much as 50 percent when treated with radiation therapy after lumpectomy. 

Poorer Women With a Breast Lump May Wait to See Doctor

NEW YORK (Reuters Health) - Poor young women are more likely to delay going to the doctor when they find a breast lump than women in better financial straits, a new study suggests.

Researchers surveyed young breast cancer patients about how they first discovered their cancer, how long they waited to see a doctor and how long after diagnosis they started treatment.

Heavy Weightlifting Safe for Women With Lymphedema, Study Suggests

Women with lymphedema — swelling in the arm caused by the surgical removal of lymph nodes or by damage to the lymph nodes from radiation therapy for breast cancer — may perform upper-body strength training exercises with light and heavy weights, without worsening swelling or other lymphedema symptoms, Australian researchers say.

Cancer Stage Related to Degree of Depression in Young African-American Women

Young African-American women with breast cancer report more symptoms of depression than their healthy peers, even when they have good social support systems and an ability to adapt to new environments or situations, a study published in the Journal of Cancer Survivorship shows.